Aatmaj Health

Why is Aatmaj Healthcare Ltd falling/rising?

As of 24-Jun, Aatmaj Healthcare Ltd's stock price is at 20.00, unchanged from the previous session, and has declined 16.84% year-to-date, underperforming the Sensex. The stock has not moved in the short term and shows bearish trends based on moving averages.

As of 24-Jun, Aatmaj Healthcare Ltd's stock price is currently at 20.00, with no change from the previous trading session (0.00%). The stock has shown a year-to-date decline of 16.84%, which is significantly worse than the Sensex's decline of 8.07% over the same period. This indicates that the stock has been underperforming relative to the broader market.<BR><BR>In the short term, the stock has not moved in the last week or month, remaining at a 0.00% change, while the Sensex has experienced a slight decline of 0.27% over the past week and a gain of 1.27% over the past month. This suggests that Aatmaj Healthcare Ltd is not keeping pace with market trends.<BR><BR>Additionally, today's performance indicates that the stock has underperformed its sector by 0.63%. The moving averages show that while the stock is higher than the 20-day moving average, it is lower than the 5-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a bearish trend.<BR><BR>Overall, the combination of a significant year-to-date decline, underperformance relative to the sector, and unfavorable moving averages contributes to the perception that Aatmaj Healthcare Ltd's stock is currently falling.

Which are the latest news on Aatmaj Health?

What does Aatmaj Health do?

Aatmaj Healthcare Ltd is a micro-cap company in the hospital industry, incorporated in 2014 and converted to a public limited company in 2022. As of September 2023, it reported net sales of 9 Cr and a net profit of 2 Cr, with a market cap of INR 43 Cr.

Overview: <BR>Aatmaj Healthcare Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Aatmaj Healthcare Ltd was originally incorporated as Aatmaj Healthcare Private Limited in 2014. The company later converted to a public limited company and changed its name to Aatmaj Healthcare Limited on December 6, 2022. The most recent quarterly results reported net sales and net profit for September 2023.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 9 Cr (Quarterly Results - Sep 2023) <BR>Most recent Net Profit: 2 Cr (Quarterly Results - Sep 2023) <BR>Market-cap value: INR 43 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 61.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.18 <BR>Return on Equity: 1.40% <BR>Price-to-Book: 0.85 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Aatmaj Health?

As of 10th June, Aatmaj Healthcare Ltd has a market capitalization of 43.00 Cr, with recent net sales of 21.99 Cr and a net profit of 5.19 Cr. As of March 2025, shareholder's funds are 50.12 Cr and total assets are 63.25 Cr.

As of 10th June, Aatmaj Healthcare Ltd has a market capitalization of 43.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>In the latest two quarters, Aatmaj Healthcare reported Net Sales of 21.99 Cr and a Net Profit of 5.19 Cr. These figures reflect the company's performance over the most recent periods.<BR><BR>The latest annual period for the balance sheet is March 2025, where Shareholder's Funds are reported at 50.12 Cr and Total Assets amount to 63.25 Cr.

Who are the peers of the Aatmaj Health?

Aatmaj Health's peers include Nephro Care, Maitreya Medica, Sangani Hospital, and others. Nephro Care shows excellent management and growth, while Aatmaj Health has average management risk and below average growth, with a 1-year return of 1.59%.

Peers: The peers of Aatmaj Health are Nephro Care, Maitreya Medica., Sangani Hospital, Nidan Laborator., Docmode Health, Shanmuga Hos., Soni Medicare, KK Shah Hospital, Fortis Malar.<BR><BR>Quality Snapshot: Excellent management risk is observed at Nephro Care, while Average management risk is found at Aatmaj Health and Shanmuga Hos. Below Average management risk is present at Maitreya Medica., Sangani Hospital, Nidan Laborator., Docmode Health, Soni Medicare, KK Shah Hospital, and Fortis Malar. Growth is Excellent at Nephro Care and Sangani Hospital, while Aatmaj Health shows Below Average growth along with Maitreya Medica., Nidan Laborator., Docmode Health, Shanmuga Hos., Soni Medicare, KK Shah Hospital, and Fortis Malar. Good capital structure is noted at Nephro Care, Aatmaj Health, Sangani Hospital, and KK Shah Hospital, while Below Average capital structure is found at Maitreya Medica., Nidan Laborator., Docmode Health, Soni Medicare, Fortis Malar, and Global Longlife.<BR><BR>Return Snapshot: Nephro Care has the highest 1-year return at -44.59%, while Maitreya Medica. has the lowest at -45.96%. Aatmaj Health's 1-year return is 1.59%, which is significantly better than both. Additionally, the six-month returns are negative for Nephro Care, Maitreya Medica., Sangani Hospital, Nidan Laborator., Docmode Health, and Global Longlife.

How has been the historical performance of Aatmaj Health?

Aatmaj Health's historical performance has shown significant volatility, with net sales and operating profit peaking in March 2023 before declining sharply by March 2025, despite growth in total assets and liabilities. Profit after tax fell from 5.91 Cr in March 2023 to 0.64 Cr in March 2025, while cash flow from operating activities improved to 3.00 Cr in March 2025 after a negative cash flow in the previous year.

Answer:<BR>The historical performance of Aatmaj Health shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aatmaj Health's net sales peaked at 27.16 Cr in March 2023 but have since declined to 19.53 Cr in March 2025. The total operating income followed a similar trend, reaching 27.16 Cr in March 2023 before dropping to 19.53 Cr in March 2025. The company's total expenditure, excluding depreciation, increased from 11.97 Cr in March 2021 to 17.98 Cr in March 2025, reflecting rising operational costs. Operating profit (PBDIT) saw a high of 9.86 Cr in March 2023 but fell to 2.87 Cr by March 2025. Profit before tax also decreased from 8.27 Cr in March 2023 to 1.07 Cr in March 2025, leading to a profit after tax of 0.64 Cr in March 2025, down from 5.91 Cr in March 2023. The company's total assets grew from 9.33 Cr in March 2020 to 63.25 Cr in March 2025, while total liabilities increased from 9.33 Cr to 63.25 Cr in the same period. Cash flow from operating activities turned positive at 3.00 Cr in March 2025, contrasting with a negative cash flow of -8.00 Cr in March 2024. Overall, Aatmaj Health has experienced a volatile financial trajectory, with notable declines in profitability despite growth in total assets and liabilities.

Who are the top shareholders of the Aatmaj Health?

The top shareholder of Aatmaj Health is promoter Tushar Karshanbhai Suvagiya, holding 46.22%. Neomile Corporate Advisory Limited is the largest public shareholder at 4.62%, while individual investors collectively own 24.96% of the shares, with no mutual funds or foreign institutional investors involved.

The top shareholders of Aatmaj Health include Tushar Karshanbhai Suvagiya, who is the promoter with the highest holding at 46.22%. Following him, the highest public shareholder is Neomile Corporate Advisory Limited, which holds 4.62%. Additionally, individual investors collectively hold 24.96% of the company's shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

Is Aatmaj Health overvalued or undervalued?

As of May 28, 2025, Aatmaj Health is overvalued with a PE ratio of 42.38 and low growth expectations, reflected in its poor financial metrics and significant underperformance compared to the Sensex.

As of 28 May 2025, Aatmaj Health has moved from a risky to a very expensive valuation grade. The company is currently overvalued, with a PE ratio of 42.38, an EV to EBITDA of 23.90, and a ROE of 1.29%. In comparison, peers such as Max Healthcare Institute Ltd. and Apollo Hospitals Enterprise Ltd. have significantly higher PE ratios of 100.29 and 69.03, respectively, indicating that Aatmaj Health's valuation is not justified by its earnings potential.<BR><BR>The company's financial metrics suggest a concerning outlook, particularly with a low ROCE of 1.43% and a PEG ratio of 0.00, which implies no growth expectations. Additionally, Aatmaj Health's stock has underperformed relative to the Sensex, showing a year-to-date decline of 19.87% compared to the Sensex's gain of 6.24%. This further reinforces the notion that the stock is overvalued in the current market environment.

What is the technical trend for Aatmaj Health?

As of May 5, 2025, Aatmaj Health's technical trend is mildly bearish, influenced by daily moving averages and monthly Bollinger Bands, despite some conflicting signals from weekly MACD and KST.

As of 5 May 2025, the technical trend for Aatmaj Health has changed from sideways to mildly bearish. The daily moving averages indicate a mildly bearish stance, while the weekly MACD and KST are mildly bullish, suggesting some conflicting signals. The Bollinger Bands show a bearish outlook on the monthly timeframe, and the OBV is mildly bearish on the weekly but mildly bullish on the monthly, indicating mixed momentum. Overall, the current technical stance is mildly bearish, driven primarily by the daily moving averages and the monthly Bollinger Bands.

When is the next results date for Aatmaj Health?

No Upcoming Board Meetings

Has Aatmaj Health declared dividend?

No Dividend History Available